Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder × ruxolitinib × 30 days × Clear all

Sponsor

Conditions

Primary Myelofibrosis 4 Thrombocythemia, Essential 3 Myeloproliferative Disorders 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Polycythemia Vera 2 Myelodysplastic Syndromes 2 Leukemia 2 Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphoma 1 Leukemia, Monocytic, Acute 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Graft vs Host Disease 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Bronchiolitis Obliterans Syndrome 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡